Merck & Co., Inc.
BG ˙ BUL ˙ US58933Y1055
SecurityBG:6MK / Merck & Co., Inc.
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership9,629 shares
Latest Disclosed Value $ 1,166,487
Intellectus Partners, LLC reports 3.91% decrease in ownership of 6MK / Merck & Co., Inc.

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 9,629 shares of Merck & Co., Inc. (BG:6MK) valued at $1,166,487 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 10,021 shares of Merck & Co., Inc.. This represents a change in shares of -3.91% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F MERCK COM 58933Y105 9,629 -392 -3.91 1,166 9.69 0.2381
2026-02-10 2025-12-31 13F MERCK COM 58933Y105 10,021 536 5.65 1,063 32.38 0.2054
2025-11-12 2025-09-30 13F MERCK COM 58933Y105 9,485 756 8.66 804 15.21 0.1557
2025-08-05 2025-06-30 13F MERCK COM 58933Y105 8,729 -3,137 -26.44 698 -35.10 0.1506
2025-04-11 2025-03-31 13F MERCK COM 58933Y105 11,866 1,797 17.85 1,075 6.44 0.2651
2025-02-07 2024-12-31 13F MERCK COM 58933Y105 10,069 3,643 56.69 1,010 38.41 0.2235
2024-11-06 2024-09-30 13F MERCK COM 58933Y105 6,426 6,426 730 0.1865
2023-10-25 2023-09-30 13F MERCK COM 58933Y105 0 -7,452 -100.00 0 -100.00
2023-07-31 2023-06-30 13F MERCK COM 58933Y105 7,452 -144 -1.90 865 6.40 0.2597
2023-05-04 2023-03-31 13F MERCK COM 58933Y105 7,596 -673 -8.14 814 -11.92 0.2569
2023-02-02 2022-12-31 13F Merck & Co Inc New Com Equity 58933Y105 8,269 -27 -0.33 923 28.19 0.3215
2022-11-14 2022-09-30 13F Merck & Co Inc New Com Equity 58933Y105 8,296 228 2.83 720 -2.83 0.2561
2022-08-12 2022-06-30 13F Merck & Co Inc New Com Common Stock 58933Y105 8,068 -43 -0.53 741 10.43 0.2546
2022-05-16 2022-03-31 13F Merck & Co Inc New Com Common Stock 58933Y105 8,111 -132 -1.60 671 5.34 0.2003
2022-02-14 2021-12-31 13F Merck & Co Inc New Com Common Stock 58933Y105 8,243 623 8.18 637 10.40 0.1624
2021-11-16 2021-09-30 13F Merck & Co Inc New Com Equity 58933Y105 7,620 539 7.61 577 3.96 0.1397
2021-08-13 2021-06-30 13F Merck & Co Inc New Com Equity 58933Y105 7,081 -12,919 -64.59 555 1,532.35 0.1251
2021-02-12 2020-12-31 13F Merck & Co Inc New Com Common Stock 58933Y105 20,000 20,000 34 0.0101
2019-08-08 2019-06-30 13F Merck & Co Inc New Com Equity 58933Y105 0 -908 -100.00 0 -100.00
2019-05-15 2019-03-31 13F Merck & Co Inc New Com Equity 58933Y105 908 0 0.00 76 8.57 0.0327
2019-02-14 2018-12-31 13F Merck & Co Inc New Com COM 58933Y105 908 -1,517 -62.56 70 -59.54 0.0480
2018-11-15 2018-09-30 13F Merck & Co Inc New Com Equity 58933Y105 2,425 0 0.00 173 16.89 0.0604
2018-08-14 2018-06-30 13F Merck & Co Inc New Com Equity 58933Y105 2,425 -262 -9.75 148 0.00 0.0540
2018-05-15 2018-03-31 13F Merck & Co Inc New Com Equity 58933Y105 2,687 372 16.07 148 12.98 0.0508
2018-02-13 2017-12-31 13F Merck & Co Inc New Com Equity 58933Y105 2,315 -300 -11.47 131 -22.49 0.0489
2017-11-14 2017-09-30 13F Merck & Co Inc New Com Equity 58933Y105 2,615 -158 -5.70 169 -5.59 0.0700
2017-08-15 2017-06-30 13F Merck & Co Inc New Com Equity 58933Y105 2,773 1,030 59.09 179 59.82 0.0806
2017-08-15 2017-06-30 13F Merck Equity 589331107 530 -1,213 34 0.0153
2017-05-08 2017-03-31 13F Merck & Co Inc Equity 58933Y105 1,743 0 0.00 112 8.74 0.0569
2017-02-14 2016-12-31 13F Merck & Co Inc Equity 58933Y105 1,743 1,743 103 0.0536
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.